This line "(perhaps implying Chimie has not been moving as quickly as CardioGenics would like and they hope these two new deals may light a fire)." is the best line as 3 large companies are now trying out the beads and as we know first to market will get the win in profit and sales.

Cardiogenics is a small and efficient 10 person operation and I would bet they can move faster than any of the large companies that they are trying to sell to. As suggested by Zacks, perhaps competition will move due process along faster.